Inhalation Devices in 7- to 15-Year-Old Children with Asthma - A Patient Preference Study

Area of Science:

• Pediatric Pulmonology
• Respiratory Medicine
• Medical Device Technology

Background:

• Inhalation therapy is crucial for managing bronchial asthma.
• Patient-specific inhaler selection is vital for adherence and reducing errors.
• Limited industry-independent data exists on children's inhaler preferences.

Purpose of the Study:

• To investigate preferences of asthmatic children for common inhaler types in Germany.
• To assess the influence of age, gender, and school type on device preference.
• To explore the role of patient education and healthcare providers in inhaler choice.

Main Methods:

• Prospective cross-sectional study of 80 children (mean age 10.87 years).
• Participants tested nine placebo inhalers (e.g., Novolizer, Spiromax, Diskus) in randomized order.
• Data collected via questionnaires and validated checklists on handling and device characteristics.

Main Results:

• Novolizer was the most favored device; Spiromax scored highest for ease of use and emergency suitability.
• No significant relationship found between preferences and age, gender, or school type.
• Significant differences in preference were observed across various inhaler features.

Conclusions:

• Novolizer and Spiromax are preferred by pediatric asthma patients over other tested devices.
• Device characteristics significantly influence patient preference.
• Inhaler choice should consider individual patient preferences for optimal asthma care.